No Data
Baikexing Biological (688276.SH) no longer recognizes Zhu Changlin as a core technical personnel.
Baike Biological (688276.SH) released an announcement that the company, based on its Global Strategy development plan, comprehensively considers the company's research and development projects...
Baikexue Bio (688276.SH): Elect Li Xiufeng as Director.
Gelonghui reported on December 10 that Baike Biotechnology (688276.SH) announced that it will hold the first meeting of the sixth Board of Directors on December 10, 2024, to review and approve the proposal regarding the election of the chairman of the sixth Board of Directors. The Board of Directors agrees to elect Mr. Li Xiufeng as the chairman of the sixth Board of Directors, with his term of office starting from the date of approval by this Board of Directors until the expiration of the sixth Board of Directors.
Changchun BCHT Biotechnology (SHSE:688276) Has A Pretty Healthy Balance Sheet
Baige Biotechnology (688276.SH) shareholder Wei Xueling's shareholding has decreased to 5%.
Baike Biotechnology (688276.SH) announced that shareholder Wei Xuening's shareholding ratio decreased from 8.7225%...
Public Companies Who Hold 41% of Changchun BCHT Biotechnology Co. (SHSE:688276) Gained 4.1%, Insiders Profited as Well
Changchun Baike Biotechnology Co., Ltd. report for the third quarter of 2024
Investors Still Waiting For A Pull Back In Changchun BCHT Biotechnology Co. (SHSE:688276)
